Amyris Inc at ROTH Conference Transcript

Mar 19, 2019 / 04:30PM GMT
Unidentified Participant

We're going to go ahead and get started on the next presentation. Very happy to have John Melo here from Amyris. He has engineered one heck of a turnaround at this Company over the last small number of years and got a long way on remediating the capital structure. I think you're going to hear a pretty compelling story. With that, I'd like to say welcome, John. Thank you.

John Melo - Amyris, Inc. - President & CEO

Good morning. I'm glad everybody has made it in this morning. I have with me, by the way, Kathy Valiasek who is our CFO, and Peter DeNardo who is our Head of Investor Relations. I appreciate all you taking a few minutes to hear a story, so let me jump right in. Again, I will be making some forward-looking statements.

So, little bit of background. How many of you are familiar with Amyris at all? So, a little, maybe a third of the room, great. So we started with a grant from the Bill and Melinda Gates Foundation, actually a passion of Bill, around curing malaria and really focused on saving children's lives. And the whole idea

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot